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Interspecies transmission of the transmissible spongiform encephalopathies (TSEs), or prion diseases, can
result in the adaptation and selection of TSE strains with an expanded host range and increased virulence such
as in the case of bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. To investigate TSE
strain adaptation, we serially passaged a biological clone of transmissible mink encephalopathy (TME) into
Syrian golden hamsters and examined the selection of distinct strain phenotypes and conformations of the
disease-specific isoform of the prion protein (PrPSc). The long-incubation-period drowsy (DY) TME strain was
the predominate strain, based on the presence of its strain-specific PrPSc following interspecies passage.
Additional serial passages in hamsters resulted in the selection of the hyper (HY) TME PrPSc strain-dependent
conformation and its short incubation period phenotype unless the passages were performed with a low-dose
inoculum (e.g., 1025 dilution), in which case the DY TME clinical phenotype continued to predominate. For
both TME strains, the PrPSc strain pattern preceded stabilization of the TME strain phenotype. These findings
demonstrate that interspecies transmission of a single cloned TSE strain resulted in adaptation of at least two
strain-associated PrPSc conformations that underwent selection until one type of PrPSc conformation and
strain phenotype became predominant. To examine TME strain selection in the absence of host adaptation,
hamsters were coinfected with hamster-adapted HY and DY TME. DY TME was able to interfere with the
selection of the short-incubation HY TME phenotype. Coinfection could result in the DY TME phenotype and
PrPSc conformation on first passage, but on subsequent passages, the disease pattern converted to HY TME.
These findings indicate that during TSE strain adaptation, there is selection of a strain-specific PrPSc
conformation that can determine the TSE strain phenotype.
The transmissible spongiform encephalopathies (TSEs) are
fatal neurodegenerative diseases of humans and animals. A
hallmark characteristic of the TSEs is the conversion of the
cellular prion protein (PrPC) to an abnormal conformation
(PrPSc) that progressively accumulates during disease (28). A
new phenotype of human Creutzfeldt-Jakob disease (CJD),
called variant CJD, that is clinically and pathologically distinct
from classic forms of CJD was first diagnosed in 1996 and
appears to be a result of interspecies transmission of bovine
spongiform encephalopathy (BSE) to humans (12, 31). The
BSE strain is highly pathogenic and is also responsible for the
BSE-related spongiform encephalopathies found in domestic
cats and many species of zoo animals (8). It has been proposed
that BSE resulted from interspecies transmission of sheep
scrapie, or a previously unrecognized TSE, to cattle via con-
taminated feed additives. Adaptation and selection of the BSE
strain from sheep scrapie or other sources was likely a result of
the recycling of BSE-contaminated cattle-derived protein sup-
plements during several cattle-to-cattle passages.
Transmission of a TSE to a new host species is an inefficient
process due to a phenomenon known as the species barrier
effect (26). This effect refers to an increase in the length of the
incubation period upon interspecies transmission compared to
the incubation period found in the donor host species. TSE
adaptation and selection occur during subsequent serial pas-
sages in the new host and lead to a reduction and eventual
stabilization of the incubation period (15). For example, the
mouse-adapted Chandler strain of scrapie has a 160-day incu-
bation period in C57BL/6 mice, but upon interspecies trans-
mission to Syrian hamsters the incubation period increases to
380 days. Additional serial passages in hamsters results in a
reduction and stabilization of the incubation period to 75 days.
One factor that can influence the species transmission barrier
is the difference in the amino acid sequence between the donor
PrPSc and the host prion protein PrPC (2, 11, 29, 30). Differ-
ences in PrP sequence can result in an inefficient propagation
of PrPSc and prolonged incubation periods upon interspecies
transmission. On second passage in the same host species, the
amino acid sequences of the donor PrPSc and host PrPC are
identical and formation of additional PrPSc is more efficient,
resulting in shorter incubation periods. In some cases, differ-
ences in the PrP sequence between the host and donor PrPs
can result in a complete interference in PrPSc formation and
development of TSE disease (29, 30).
Interspecies TSE transmission can lead to the maintenance
of the original strain phenotype or a change in the TSE strain
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phenotype. The selection of TSE strains that have an advan-
tage in the new host is illustrated by the serial transmission of
the drowsy goat source of scrapie into rats, mice, and hamsters
(20). Early hamster passages identified strain 431K that main-
tained pathogenicity for mice, but after several additional pas-
sages in hamsters, strain 263K was the only strain present. The
selection of 263K was accompanied by a shortening of the
incubation period and a loss of pathogenicity in mice. This
suggested that 431K was the original or dominant murine
pathogen, but passage into hamsters selected for, or gave rise
to, the variant 263K strain that had a selective advantage in
hamsters. The TSE strain with the shortest incubation period
in the new host species is the predominate one found between
the second and fifth intraspecies serial passage (20, 21). The
dose of each TSE strain in the mixture is also likely to influence
the outcome of interspecies transmission and subsequent se-
lection upon intraspecies passage (20).
The basis of TSE strain diversity is proposed to be deter-
mined by either differences in the conformation of PrPSc
among strains (4, 5, 7, 27) or mutation of the putative TSE
nucleic acid genome (9). To investigate the molecular basis of
TSE adaptation and selection upon interspecies transmission,
we used a model of transmissible mink encephalopathy (TME)
in Syrian hamsters (6, 24). Previously, we identified two strains
of TME after interspecies passage into hamsters that were
called hyper (HY) and drowsy (DY) TME. Phenotypic prop-
erties between these TME strains differed with respect to in-
cubation period (e.g., 65 versus 165 days), clinical signs (e.g.,
hyperexcitability and ataxia versus progressive lethargy), neu-
ropathology, brain distribution of PrPSc, and TME brain titers
(4, 5). PrPSc isolated from the brains of HY and DY TME-
infected hamsters exhibit strain-specific conformations based
on differences in sedimentation properties, susceptibility to
protease cleavage, N-terminal cleavage sites by proteases, and
b-sheet secondary structure (4, 5, 13). Using a PrP cell-free
conversion assay, PrPC could be converted into a PrP molecule
resembling the HY or DY PrPSc strain-specific conformation
when directly incubated with the respective PrPSc strains, in-
dicating that a similar PrPC molecule can be folded into mul-
tiple conformations via direct PrPC-PrPSc interactions (3).
These findings support the protein-only model on the nature of
the TSE agent and TSE strain diversity. We now report that
interspecies transmission of a biological clone of TME results
in the adaptation of both the HY and DY strain-specific PrPSc
conformations, often present as a mixture, which can undergo
selection during subsequent intraspecies hamster passage. The
PrPSc strain pattern was found prior to stabilization of the
TME strain phenotype, indicating that the PrPSc conformation
can determine TSE biological characteristics. Furthermore,
direct competition studies between HY and DY TME demon-
strated that changes in the PrPSc conformation accompany a
switch in TME phenotypes.
MATERIALS AND METHODS
Biological cloning of TME in mink. To produce a biological clone of the
Stetsonville TME agent, we performed a series of endpoint dilution experiments
as described previously (9). A TME-infected mink brain from the Stetsonville
ranch was homogenized to 10% (wt/vol) in phosphate-buffered saline (PBS)
using disposable syringes and plasticware. Serial 10-fold dilutions of brain ho-
mogenates (1021 to 1028) were intracerebrally (i.c.) inoculated into weanling
mink. Control animals were inoculated with PBS alone. All animals were ob-
served weekly for the onset of neurological disease. Clinically ill animals were
sacrificed by CO2 asphyxiation, and brain tissue was removed with new instru-
ments.
The biological clone of the Stetsonville TME agent (24) was prepared from
brain tissue of a TME-positive mink that received the highest dilution of inoc-
ulum. The brain was subsequently homogenized in PBS and two additional serial
10-fold dilutions of the brain homogenate, and inoculations were performed in
order to obtain TME inocula that had the highest likelihood of containing a
single strain of TME agent.
Interspecies transmission experiments. Weanling Syrian golden hamsters
were i.c. inoculated with 30 ml of a 10% (wt/vol) TME brain homogenate that was
biologically cloned in mink by three successive endpoint dilution experiments.
Control animals were inoculated with buffer alone. All animals were observed
daily for the onset of neurological disease as described previously (6). Animals
were sacrificed by CO2 asphyxiation, and brain tissue was removed using new
surgical instruments designated for these studies. Brains from individual animals
were homogenized using disposable syringes and plasticware. Serial hamster-to-
hamster passages were performed by i.c. inoculation at dilutions of 1021 or 1025.
Up to five additional hamster passages were performed, depending on the time
at which incubation period and clinical signs stabilized.
Hamster TME competition experiments. Syrian golden hamsters were i.c.
inoculated with either biologically cloned DY TME (1022 brain dilution or 105.4
50 lethal doses per g of tissue) or biologically cloned HY TME (1026 to 1029
brain dilutions or 103.8 to 100.8 50% lethal doses per g of tissue) alone or with a
mixed inoculum containing DY TME (1022 brain dilutions) and HY TME at
either 1026, 1027, 1028, or 1029 dilutions. Brain titers were calculated by end-
point dilution analysis using the Ka¨rber method (25). Animals exhibiting clinical
signs of neurological TME disease were sacrificed, and brain material was serially
passaged at a 1022 dilution as described above.
Tissue preparations and PrPSc Western blot analysis. Two protocols were
used for the preparation of brain material for PrPSc analysis. In the abbreviated
protocol, a 10% (wt/vol) brain homogenate was digested with proteinase K (50
mg/ml) for 30 min at 37°C. Phenylmethylsulfonyl fluoride was added to 5 mM.
For the second method, brain tissue was homogenized to 10% (wt/vol) in 10%
sarcosyl in buffer A (10 mM Tris [pH 8.3], 133 mM NaCl, 1 mM EDTA, and 1
mM dithiothreitol). Following ultracentrifugation in a Beckman Instruments
TLA-45 rotor at 20,000 rpm (22,000 3 g) for 20 min in a TL-120 ultracentrifuge,
the supernatant was removed and centrifuged in a TLA-45 rotor at 45,000 rpm
(125,000 3 g) for 1 h. The pellets were resuspended in Tris-buffered saline (1 ml
per g of tissue), proteinase K was added to 10 mg/ml, and the mixture was
incubated at 37°C for 1 h. Phenylmethylsulfonyl fluoride was added to 5 mM, and
the preparation was brought to 1% sarcosyl–10% NaCl in buffer A. Following
ultracentrifugation in a TLA-45 rotor at 45,000 rpm for 1 h, the pellet was
washed and resuspended in sample buffer for sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE).
Brain samples were analyzed by SDS-PAGE (15% gel), transferred to Immo-
bilon P membrane (Millipore), and incubated with monoclonal antibody 3F4
(1:40,000; a gift from Richard Kascsak, Institute for Basic Research in Devel-
opmental Disabilities [18]) or rabbit polyclonal R20 (1:3,000; a gift from Byron
Caughey, NIH Rocky Mountain Laboratories [14]) for 2 h at room temperature
or at 4°C overnight as described previously (5). The secondary antibody used was
either anti-mouse immunoglobulin G conjugated to alkaline phosphatase (1:
1,000; Sigma, St. Louis, Mo.) or goat anti-mouse immunoglobulin G conjugated
to horseradish peroxidase (1:1,000; Bio-Rad Laboratories, Hercules, Calif.). De-
tection of the immunoblot signal was performed using the nitrobluetetrazolium
method or chemiluminescence (Amersham).
RESULTS
Interspecies transmission of cloned TME. A biological clone
of the Stetsonville TME isolate was produced by 10-fold serial
dilutions of a mink brain homogenate and inoculation into
pastel mink. The brains from the animals that developed TME
after receiving the highest dilution of inocula (e.g., 1025 or
1026) were collected, and endpoint dilutions and inoculations
were repeated two additional times. This approach has been
used to isolate a homogenous population of a single TSE strain
from a mixture containing more than a single strain (9).
Four independent biological clones of mink-passaged TME
were i.c. inoculated into a total of 88 Syrian golden hamsters,
and the incubation periods, clinical symptoms, and PrPSc pat-
terns were determined. For TME clone 4, disease was ob-
served in 12 out of 21 hamsters with an incubation period
ranging from 219 to 522 days (x# 5 450 6 83 days [standard
error of the mean]; Table 1). Analysis of PrPSc after limited
proteinase K digestion (of 7 out of 12 clinically affected ham-
sters) revealed that six (incubation period 5 473 6 24 days)
had a polypeptide banding pattern characteristic of the DY
TME strain in hamsters. This pattern was characterized by
three polypeptide bands (i.e., unglycosylated, monoglycosy-
lated, and diglycosylated isoforms of PrP) ranging from 19 to
29 kDa (i.e., 19-kDa pattern; Fig. 1B, lane DY) (6). The one
remaining PrPSc pattern (incubation period 5 219 days) was
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similar to that of the HY TME strain, which has a molecular
size ranging from 21 to 31 kDa and will be referred to as the
21-kDa pattern (Fig. 1B, lane HY). The clinical symptoms
upon interspecies transmission to hamsters were not charac-
teristic of the hamster-adapted HY and DY TME strains de-
scribed previously but were variable in type and duration. The
results from TME clone 4 were similar to those obtained for
the other three biological clones of TME (data not shown).
Two additional criteria were used in discriminating the HY
and DY PrPSc 21- and 19-kDa banding patterns. The migration
distance of the top edge of the diglycosylated PrPSc band at
approximately 30 kDa also differs by 1 to 2 kDa between the
TME strains (Fig. 2). In addition, rabbit polyclonal antibody
R20, which is directed to the C-terminal portion (i.e., amino
acids 218 to 232) of the murine prion protein, has stronger
immunoreactivity in the 6- to 8-kDa molecular size range of
DY PrPSc compared to HY PrPSc (Fig. 2).
Intraspecies transmission of TME. Additional serial pas-
sages of the hamster-passaged cloned TME agent into Syrian
hamsters resulted in a reduction of the incubation period and
the selection of distinct TME strain phenotypes. Two individ-
ual hamsters inoculated with TME clone 4 were further pas-
saged at a 1022 dilution into six hamsters. The most common
outcome of second passage of the TME clones into hamsters is
illustrated in passage line A (Fig. 1A). Passage of animal 11,
which had an incubation of 501 days and the 19-kDa PrPSc
pattern, resulted in an incubation period of 167 6 10 days (n 5
6), the 19-kDa PrPSc pattern, and clinical signs predominantly
of lethargy but with some evidence of hyperexcitability. Since
these animals did not exhibit the classical HY or DY clinical
signs, they were considered to represent a syndrome sharing
features of both phenotypes. At the next passage, the dilution
of the brain inocula was an important determinant for the
outcome of TME strain selection. Third hamster passage with
a 1021 brain dilution inoculum resulted in an incubation pe-
riod of 129 6 4 days, no change in the clinical symptoms, and
a mixture of the 19- and 21-kDa PrPSc patterns (Fig. 1C, lane
3). The transition from DY to HY TME continued at fourth
hamster passage, where the incubation period (i.e., 59 6 2
days), clinical symptoms, and 21-kDa PrPSc band pattern char-
acteristic of HY TME were found. However, third hamster
passage at a 1025 brain dilution from the same animal having
a 159-day incubation period resulted in an increase in the
incubation period to 193 6 11 days, clinical disease character-
ized by a progressive lethargy, and the 19-kDa PrPSc pattern
(Fig. 1A, passage line A). This DY TME phenotype was main-
tained on additional passages at low dilutions (e.g., 1022).
Similar results were obtained from the other TME clones.
Two additional but less frequent outcomes were found in
passage line A during second passage. In one group, the HY
TME strain emerged similar to that observed in passage line B
on second and third passages (see below), while in a third
group, the DY TME clinical symptoms and 19-kDa PrPSc pat-
tern stabilized by the third passage (data not shown). In pas-
sage line B, brain inocula from animal 6, which had an incu-
bation period of 219 days and a 21-kDa PrPSc pattern, resulted
in an incubation period of 67 6 3 days, the HY TME clinical
phenotype characterized by hyperexcitability, tremor, and
ataxia, and the 21-kDa PrPSc banding pattern (Fig. 1A and B,
passage line B). Third passage using an individual animal from
this group (incubation period of 66 days) resulted in stabiliza-
tion of the HY TME PrPSc banding pattern and clinical phe-
notype. The results from intraspecies transmission using TME
clone 4 as the inoculum were similar to those obtained for the
other three biological clones of TME (data not shown).
FIG. 1. Transmission of a biological clone of TME to hamsters. (A) Serial
transmission of TME into hamsters is indicated in passage lines A and B. On first
passage, the animal numbers refer to Table 1, with incubation period in days
(d.) 6 standard error of the mean and clinical phenotype, when apparent, noted
as either HY, DY, or HD, a combination of both. Incubation periods without a
standard error of the mean refer to individual animals that were used for both
PrPSc analysis and subsequent passages. The PrPSc polypeptide migration pat-
tern (19 or 21 kDa) is indicated; numbers 1, 2, and 3 refer to animals whose PrPSc
patterns were analyzed in panels B and C. (B and C) Western blot analysis of
PrPSc from first interspecies passage (lanes 1 and 2) and second intraspecies
hamster passage (lane 3). Brain samples were resolved by SDS-PAGE (15% gel),
and PrP was detected with monoclonal antibody 3F4 as described in Materials
and Methods. Lanes HY and DY are the control 21- and 19-kDa patterns,
respectively.
TABLE 1. Interspecies transmission of biologically cloned
TME to Syrian hamsters
Animal
no.
PrPSc pattern
(kDa)
Incubation
period (days)
1 19 446
2 NDa 501
3 ND 522
4 19 473
5 ND 473
6 21 219
7 ND 383
8 19 501
9 ND 501
10 19 453
11 19 501
12 19 461
13–21 ND .600
a ND, not determined.
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Intraspecies competition of HY and DY TME. To test the
hypothesis that low levels of HY TME can emerge from a
combined infection of HY and DY TME that initially exhibits
a DY TME phenotype, hamsters were coinfected with biolog-
ically cloned HY and DY TME. Clinical disease, incubation
period, and PrPSc pattern were investigated during several
serial passages.
In the intraspecies competition experiment, hamsters were
coinfected with a 1022 brain homogenate of DY TME and
increasing brain dilutions (e.g., 1026 to 1029) of HY TME-
infected brain homogenates. All passages after the initial coin-
fection experiment were performed at a brain inoculum dilu-
tion of 1022. Three patterns of TME disease were found,
depending on the dose of each strain: (i) the short incubation
HY TME phenotype and strain-specific PrPSc pattern was es-
tablished and maintained (Table 2, trial A; Fig. 2, lanes 1 to 3);
(ii) the DY TME or mixed pattern found on first passage
reverted to the HY TME phenotype after additional passages
(Table 2, trial B; Fig. 2, lanes 4 to 11); and (iii) the DY TME
strain was able to block the selection of the short incubation
HY TME strain (Table 2, trial C; Fig. 2, lanes 12 to 16).
The selection of HY TME from animals exhibiting the DY
TME phenotype was found when hamsters were coinfected
with brain dilutions of HY TME at 1027 and DY TME at 1022
(Table 2, trial B). At first passage, one animal with an incuba-
tion period of 126 days exhibited a HY TME clinical pheno-
type and a 21-kDa PrPSc pattern that was maintained on sec-
ond serial passage in which the incubation period shortened to
68 6 2 days. The remaining four animals had incubation pe-
riods ranging from 148 to 160 days and exhibited clinical symp-
toms of DY TME. Two had the 19-kDa PrPSc banding pattern
(Fig. 2, lanes 6 and 7), while the remaining two had an inter-
mediate size banding pattern that was between the 19- and
21-kDa patterns and could represent a mixture of HY and DY
FIG. 2. PrPSc polypeptide patterns from Syrian hamsters infected with the HY and DY strains of TME. Animals were infected with different combinations and
dilutions of HY and DY TME as indicated in each of the trials reported in Table 2 and also illustrated above each lane. Each lane contains an enriched PrPSc brain
fraction digested with proteinase K from an individual animal and analyzed by SDS-PAGE and Western blot analysis using monoclonal antibody 3F4 (lanes 1 to 3 and
12 to 21) or rabbit polyclonal antibody R20 (lanes 4 to 11). R20 is immunoreactive to a synthetic peptide containing the C-terminal end of the mature prion protein;
in addition to recognizing similar-molecular-weight PrP polypeptides as 3F4, it can also detect a 6- to 8-kDa band. Boxed areas refer to the second serial passage,
inoculated at a 1022 brain dilution, of individual brains from the first passage. HY and DY TME control PrPSc banding patterns are indicated in lanes 1, 4, 11, 16, and
21 and in lanes 1 and 11, respectively.
TABLE 2. HY and DY TME competition experiment
Trial
Inoculum dilution 1st passage 2nd passage
HY DY Mean incubationperiod (days) 6 SEM
Clinical
symptoms
PrPSc pattern
(kDa)
Mean incubation
period (days) 6 SEM
Clinical
symptoms
PrPSc pattern
(kDa)
A 1026 107 6 1 (5/5a) HY 21 61 6 1 (4/4) HY 21
1022 158 6 2 (6/6) DY 19 157 6 3 (4/4) DY 19
1026 1022 104 6 1 (5/5) HY 21 55 6 2 (4/4) HY 21
B 1027 154 6 22 (5/5) HY 21 NDb ND ND
1027 1022 126 HY 21 68 6 2 (5/5) HY 21
1027 1022 148 DY 19 61 6 0 (6/6) HY 21
1027 1022 155 DY 19 75 6 0 (6/6) HY 21
1027 1022 155 DY 19/21 75 6 0 (5/5) HY 21
1027 1022 160 DY 19/21 81 6 3 (5/5) HY 19/21
C 1028 190 6 22 (5/5) HY 21 ND ND ND
1028 1022 122 HY 21 66 6 0 (5/5) HY 21
1028 1022 150 DY 19 143 6 2 (6/6) DY 19
1028 1022 150 DY 19 147 6 2 (5/5) DY 19
1028 1022 155 DY 19 154 6 7 (6/6) DY 19
D 1029 .400 (5/5) None ND ND ND ND
1029 1022 147 DY 19 133 6 0 (4/4) DY 19
1029 1022 154 DY 19 137 6 0 (4/4) DY 19
a Number affected/number inoculated.
b ND, not determined.
VOL. 74, 2000 SELECTION OF PrPSc CONFORMATIONS 5545
 
 
PrPSc (Fig. 2, lane 5, and data not shown). In the second
passage performed at a 1022 brain dilution, all of the DY TME
animals reverted to a HY TME clinical phenotype and the
incubation periods shortened to between 61 and 81 days. The
PrPSc banding pattern switched to the 21-kDa pattern (Fig. 2,
lanes 8 and 10); in one case, an intermediate PrPSc pattern
between the 19- and 21-kDa patterns was found (Fig. 2, lane
9). Rabbit polyclonal antibody R20, directed to a synthetic
peptide corresponding to the C-terminal portion of the prion
protein, was used to aid in identification of the HY and DY
TME banding patterns. Antiserum R20 immunoreacts with a
6- to 8-kDa PrPSc band present in control DY TME hamster
brain (Fig. 2, lane 11) but only weakly reacts with this PrPSc
band from the control HY TME brain (Fig. 2, lane 4).
DISCUSSION
The interspecies and intraspecies transmission of a biologi-
cal clone of TME was investigated by monitoring the adapta-
tion and selection of TME strains through evaluation of the
PrPSc banding patterns, incubation periods, and clinical symp-
toms. Two distinct PrPSc banding patterns were detected prior
to the stabilization of the HY and DY TME clinical pheno-
types. In some hosts a mixture of the 19- and 21-kDa PrPSc
patterns and clinical symptoms characteristic of both strains
were found; in these cases, the shorter incubation HY TME
strain was predominant on subsequent serial passages indicat-
ing that strain selection determines the emergence of strain
phenotypes. Direct evidence for TME strain selection was pro-
vided by coinfection with predetermined amounts of each
strain. High doses of DY TME were able to interfere with low
titers of HY TME and cause partial or complete interference
of the HY PrPSc banding pattern and clinical phenotype. A
mixture of PrPSc banding patterns could be found in hosts that
switched from a DY to HY phenotype in a single passage,
indicating the selection of the HY TME strain. These findings
provide the first evidence for selection of TSE strains at the
molecular level.
In a previous study, transmission of the Stetsonville TME
field isolate to hamsters resulted in the identification of the HY
and DY TME strains (6). In the present study, the Stetsonville
TME field isolate was cloned by limiting dilution in mink in
three consecutive passage experiments in order to isolate the
single predominant mink strain. The TME biological mink
clone had a similar transmission history in hamsters as the
Stetsonville field isolate, suggesting that upon interspecies
transmission, two hamster-adapted TME strains emerged from
a single mink TME strain. Although it cannot be ruled out that
more than a single pathogenic PrPSc conformation exists in the
biologically cloned inoculum, we propose that the ability of the
donor mink PrPSc to convert the host hamster PrPC into more
than one stable hamster PrPSc conformation can give rise to
multiple TME strains.
An alternative explanation for the emergence of TSE strains
from a biological clone is a mutation in the putative TSE
nucleic acid genome, despite a lack of a candidate molecule (1,
9, 10). The current findings provide molecular evidence that
two distinct PrPSc patterns were found upon interspecies pas-
sage of a biological clone into a new host species. Furthermore,
these PrPSc conformations could determine, or be used to
predict, which strain will emerge upon additional passage. The
strain-specific PrPSc patterns also were consistently found prior
to stabilization of the TME phenotype in hamsters and there-
fore could be the molecular determinant of strain phenotype
and preclude the requirement for a nucleic acid genome.
Three distinct TME strain patterns were observed upon
interspecies transmission of cloned TME to hamsters: estab-
lishment of either the HY or DY TME phenotype during
second or third hamster passage without evidence of mixed
infection, and an indirect route in which a mixture of HY and
DY TME was initially observed and led to the selection of
either one of the TME strains upon additional passage. It
appears that the DY TME strain was responsible for clinical
disease upon interspecies transmission since the 19-kDa PrPSc
pattern was most often found. DY TME likely represents the
pathogenic strain present in the cloned mink inocula. Selection
of the HY TME strain occurred after additional passage be-
cause it has a shorter incubation period than DY TME even
though it was initially present at lower doses. Once the HY
TME phenotype and PrPSc pattern were found, they never
reverted to the DY TME strain. It is difficult to resolve
whether the HY TME strain was generated de novo upon
interspecies transmission or was present at low levels in the
cloned TME inoculum. However, the findings that the HY
TME agent could be eliminated after a single 1025 dilution of
second hamster passage TME indicates that it was unlikely that
the biologically cloned TME agent contained a minor popula-
tion of HY TME. Furthermore, previous studies demonstrated
that hamster-adapted HY TME loses its pathogenicity in mink
(6). These observations strongly support the concept of adap-
tation of the HY strain-specific PrPSc conformation upon in-
terspecies transmission and the selection of HY TME upon
additional hamster passages.
TME strain selection during coinfection with biological
clones of HY and DY TME support the interspecies transmis-
sion findings that in a mixed TME infection, small doses of the
short-incubation-period HY TME require additional animal
passages in order to outcompete the long-incubation-period
DY TME. The transition from the DY to HY TME phenotype
corresponded with a switch in the PrPSc banding pattern. This
was observed when DY TME titer was inoculated with a 100-
and 1,000-fold excess with respect to HY TME and was fol-
lowed by an additional passage. Complete interference of HY
TME could be achieved in a mixed TME infection when the
titer of the DY TME was greater than 1,000-fold excess over
HY TME in the inoculum. In this case, the DY TME pheno-
type was maintained upon two additional serial passages;
therefore, the HY TME agent could not be recovered when
provided the opportunity to replicate. These findings were
confirmed at the molecular level by the propagation of the
21-kDa DY TME banding pattern. Our results have similari-
ties to a competition study between mouse-adapted strains of
scrapie upon intraspecies infection (16, 17). In that study, the
long-incubation (i.e., 550 days) 22A strain interfered with the
short-incubation (i.e., 230 days) scrapie strain 22C when 22A
was inoculated at least 100 days prior to 22C. Both the incu-
bation period and brain neuropathology were characteristic of
22A despite the delayed coinfection with the faster-replicating
22C strain and indicated that the long-incubation pathogen
blocked the replication sites of the short-incubation agent. An
additional passage from animals coinfected with 22A and 22C
was not performed, but we speculate that the shorter incuba-
tion 22C strain would not have emerged since a mixture of the
22A and 22C neuropathological lesion profiles or incubation
periods was not observed. This is in contrast to the present
study, in which a mixture of the HY and DY PrPSc patterns
could give rise to either TME strain phenotype or PrPSc band-
ing pattern, depending on the dose of inoculum.
A model for TSE strain adaptation and selection at the
molecular level following interspecies transmission is proposed
based on both the current findings of TME transmission to
hamsters and previous transmission studies (5, 6, 19, 20–23,
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29). Two events likely occur upon interspecies TSE transmis-
sion: (i) TSE strain adaptation involves the conversion of host
PrPC to PrPSc by a donor PrPSc molecule having a different
primary structure (i.e., responsible for the species barrier ef-
fect) and (ii) the formation of multiple PrPSc conformations
from a single donor PrPSc conformation that is responsible for
generation of TSE strains. During intraspecies transmission,
the selection of TSE strain phenotypes results from competi-
tion among the multiple PrPSc conformations. The outcome of
TSE strain selection is dependent on the dose of each strain
and kinetics of agent replication. This can result in propagation
of several PrPSc strain-specific conformations or in interfer-
ence with the formation of a particular PrPSc conformation. In
the case of a mixture of strain-specific PrPSc conformations,
the more rapidly propagating PrPSc strain in the new host
species will predominate after additional passages. However, if
the PrPSc conformation of a long incubation TSE strain is
present at high doses, then it could interfere with the manifes-
tation of a rapid onset TSE strain PrPSc conformation and
phenotype.
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